Mira1a Therapeutics announced it raised $625,000 in an initial filing from an offering of $3 Million
Mira1a Therapeutics announced it raised $625,000 in an initial filing from an offering of $3 Million
08/01/22, 9:15 PM
Location
baltimoreMoney raised
$625,000
Industry
healthcare
Round Type
seed
Company Info
Location
855 n wolfe street #601
baltimore, maryland, united states
Additional Info
MIRA1a is being developed as the first prescription drug to target the CB1 and CB2 receptors for chronic pain and anxiety without the impurities of marijuana or its side effects such as increased appetite and paranoia.